Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Initiation of phase II trial of MVA-HPV-IL-2 in cervical intraepithelial neoplasia

March 1, 2002

Polypeptide CASB761 described in patent

Feb. 27, 2002

WX-G250 shows antitumor activity and very good tolerance in RCC

Feb. 25, 2002

Scancell develops apoptosis-inducing and anti-growth factor antibodies

Feb. 25, 2002

Orphan drug status granted for SS1-PE38 in mesothelioma and ovarian cancer

Feb. 19, 2002

Hollis-Eden collaborating on development of Aeson's lead compound

Feb. 19, 2002

Compounds that enhance transcription factor AP-1 designed at Active Biotech

Feb. 18, 2002

Phase II trial of CeaVac and TriAb initiated in metastatic colorectal cancer

Feb. 12, 2002

Biomira initiates phase II trial of Theratope vaccine in metastatic colorectal cancer

Feb. 11, 2002

SciClone updates progress of Zadaxin

Feb. 11, 2002

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...